Research output per year
Research output per year
Personal profile
Research interests
Charlotte Teunissen (full professor in Neurochemistry) aims to improve care of patients with neurological diseases by developing body fluid biomarkers for diagnosis, stratification, prognosis and monitoring treatment responses. Studies of her research group span the entire spectrum of biomarker development, starting with biomarker identification, followed by assay development and validation, and extensive clinical validation to ultimately implement novel biomarkers in clinical practice.
She is responsible for the Alzheimer Center Amsterdam body fluid and leads several international biomarker networks, such as the CSF Society and the Alzheimer Association-Global Biomarker Standardization consortium, and the recently founded Coral proteomics consortium. She is the coordinator of the Marie Curie MIRIADE project, aiming to train 15 novel researchers into accelerate dementia biomarker development.
Education/Academic qualification
PhD, Towards an in vitro diagnosis for neurodegeneration, Universiteit Maastricht
Award Date: 29 Nov 2001
Master, Wageningen University & Research, Wageningen, Netherlands
Award Date: 1 Jul 1997
Keywords
- R Medicine (General)
Fingerprint
Dive into the research topics where Charlotte Teunissen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
-
Frequent Home Monitoring in Multiple Sclerosis
Verberk, I. (CoPI), Teunissen, C. (Principal investigator) & Schumacher, M. (Project Leader)
Project: Research
-
-
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
Hansson, O., Edelmayer, R. M., Boxer, A. L., Carrillo, M. C., Mielke, M. M., Rabinovici, G. D., Salloway, S., Sperling, R., Zetterberg, H. & Teunissen, C. E., 1 Dec 2022, In: Alzheimer s & dementia. 18, 12, p. 2669-2686 18 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile73 Downloads (Pure) -
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M. & del Campo, M., 22 Jan 2021, In: The Lancet Neurology. 21, 1, p. 66-77 12 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile1456 Downloads (Pure) -
Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease–related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group
Verberk, I. M. W., Misdorp, E. O., Koelewijn, J., Ball, A. J., Blennow, K., Dage, J. L., Fandos, N., Hansson, O., Hirtz, C., Janelidze, S., Kang, S., Kirmess, K., Kindermans, J., Lee, R., Meyer, M. R., Shan, D., Shaw, L. M., Waligorska, T., West, T. & Zetterberg, H. & 2 others, , 2021, (E-pub ahead of print) In: Alzheimer's and Dementia.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile116 Downloads (Pure) -
Alzheimer's disease
Scheltens, P., de Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J. & van der Flier, W. M., 24 Apr 2021, In: The Lancet. 397, 10284, p. 1577-1590 14 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile13 Downloads (Pure) -
Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
Verberk, I. M. W., Thijssen, E., Koelewijn, J., Mauroo, K., Vanbrabant, J., de Wilde, A., Zwan, M. D., Verfaillie, S. C. J., Ossenkoppele, R., Barkhof, F., van Berckel, B. N. M., Scheltens, P., van der Flier, W. M., Stoops, E., Vanderstichele, H. M. & Teunissen, C. E., 28 Sept 2020, In: ALZHEIMERS RESEARCH & THERAPY. 12, 1, p. 118 118.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile58 Downloads (Pure)
-
'Meet the Experts' Round Table
van der Flier, W. (Speaker), Teunissen, C. (Keynote speaker) & van Harten, A. (Speaker)
12 May 2022Activity: Talk or presentation › Invited talk › Academic
-
Neurovision and Biomarable Collaborative Alliance
Teunissen, C. (Participant)
2019Activity: Educational contribution / Supervising student theses, products › Other
-
Center Of Excellence Roche, Strategic Alliance
Teunissen, C. (Participant)
2019Activity: Educational contribution / Supervising student theses, products › Other
Prizes
-
Biannual Trophee for young talented translational researchers
Teunissen, C. (Recipient), 2004
Prize › Academic
-
Press/Media
-
Real-world diagnostic performance of blood-based biomarkers for Alzheimer’s disease: robust performance except after stroke and high charlson comorbidity index
Vigneswaran, S., Rousset, R. Z., Trieu, C., Claessen, T., Lemstra, A. W., van der Flier, W. M., Teunissen, C. E. & van Harten, A. C.
01/02/2026
1 Media contribution
Press/Media: other
-
Plasma and MRI biomarkers capture neuronal damage in former professional boxers
Kamps, S., van Amerongen, S., Hoppen, M. I., Bongers, B., Caton, D. K., Konigs, M., Teunissen, C. E., Scheltens, P. & Ossenkoppele, R.
01/06/2025
1 Media contribution
Press/Media: other
-
Implications of AD plasma and PET biomarker discordance
Teunissen, C. E. & Vermunt, L.
01/05/2025
1 Media contribution
Press/Media: other
-
Novel CSF β-synuclein-specific assays signal early synaptic degeneration in Alzheimer’s disease
van der Flier, W. M., Teunissen, C. E. & Verberk, I. M. W.
01/04/2025
1 Media contribution
Press/Media: other
-
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
Ossenkoppele, R., Coomans, E. M., van der Flier, W. M. & Teunissen, C. E.
01/03/2025
1 Media contribution
Press/Media: other
Datasets
-
Additional file 2 of CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals
Del Campo, M. (Contributor), Quesada, C. (Creator), Vermunt, L. (Creator), Peeters, C. F. W. (Creator), Hok-A-Hin, Y. S. (Creator), Trieu, C. (Creator), Braber, A. D. (Creator), Verberk, I. M. W. (Creator), Visser, P. J. (Creator), Tijms, B. M. (Creator), van der Flier, W. M. (Creator) & Teunissen, C. E. (Creator), Figshare, 2024
DOI: 10.6084/m9.figshare.27644842, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_CSF_proteins_of_inflammation_proteolysis_and_lipid_transport_define_preclinical_AD_and_progression_to_AD_dementia_in_cognitively_unimpaired_individuals/27644842
Dataset
-
Additional file 3 of CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals
Del Campo, M. (Contributor), Quesada, C. (Creator), Vermunt, L. (Creator), Peeters, C. F. W. (Creator), Hok-A-Hin, Y. S. (Creator), Trieu, C. (Creator), Braber, A. D. (Creator), Verberk, I. M. W. (Creator), Visser, P. J. (Creator), Tijms, B. M. (Creator), van der Flier, W. M. (Creator) & Teunissen, C. E. (Creator), Figshare, 2024
DOI: 10.6084/m9.figshare.27644845, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_CSF_proteins_of_inflammation_proteolysis_and_lipid_transport_define_preclinical_AD_and_progression_to_AD_dementia_in_cognitively_unimpaired_individuals/27644845
Dataset
-
Additional file 2 of CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals
Del Campo, M. (Contributor), Quesada, C. (Creator), Vermunt, L. (Creator), Peeters, C. F. W. (Creator), Hok-A-Hin, Y. S. (Creator), Trieu, C. (Creator), Braber, A. D. (Creator), Verberk, I. M. W. (Creator), Visser, P. J. (Creator), Tijms, B. M. (Creator), van der Flier, W. M. (Creator) & Teunissen, C. E. (Creator), Figshare, 2024
DOI: 10.6084/m9.figshare.27644842.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_CSF_proteins_of_inflammation_proteolysis_and_lipid_transport_define_preclinical_AD_and_progression_to_AD_dementia_in_cognitively_unimpaired_individuals/27644842/1
Dataset
-
Additional file 3 of CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals
Visser, P. J. (Creator), Peeters, C. F. W. (Creator), Tijms, B. M. (Creator), Teunissen, C. E. (Creator), Quesada-González, C. (Contributor) & Hok-A-Hin, Y. S. (Creator), Figshare, 2024
DOI: 10.6084/m9.figshare.27644845.v1, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_CSF_proteins_of_inflammation_proteolysis_and_lipid_transport_define_preclinical_AD_and_progression_to_AD_dementia_in_cognitively_unimpaired_individuals/27644845/1
Dataset